Go to content
UR Home

Topical Administration of Mometasone Is Not Helpful in Post-COVID-19 Olfactory Dysfunction

URN to cite this document:
DOI to cite this document:
Hintschich, Constantin A. ; Dietz, Melanie ; Haehner, Antje ; Hummel, Thomas
[img]License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 28 Sep 2022 08:31


Persistent olfactory dysfunction is a major concern post-COVID-19, affecting up to 5% of all patients. Different therapeutic options, including mometasone nasal spray, have been recommended, only some of which have been validated for post-COVID-19 olfactory dysfunction. In this study we psychophysically assessed the effect of intranasally applied mometasone furoate on the recovery of olfaction. ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons